Clinical trials recruiting for Ductal Carcinoma In Situ, DCIS
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Adjuvant Radiotherapy | 1 |
| Endocrine Therapy (Optional) | 1 |
| Tamoxifen | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| New York | 1 |
Top cities
Self-screener
Recruiting trials
- Omission of Adjuvant Radiotherapy in Low- and Intermediate-Risk Ductal Carcinoma In Situ After Breast-Conserving Surgery
- Omission of Adjuvant Radiotherapy in Young Low-Risk Ductal Carcinoma In Situ Following Breast-Conserving Surgery
- Personalized Prone Immobilization for Accelerated Partial Breast Radiotherapy
Related conditions
Trials recruiting for Ductal Carcinoma In Situ, DCIS often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Ductal Carcinoma In Situ, DCIS trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.